• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向非常规途径以寻求新型抗真菌药物

Targeting Unconventional Pathways in Pursuit of Novel Antifungals.

作者信息

Nguyen Stephanie, Truong Jia Q, Bruning John B

机构信息

Institute of Photonics and Advanced Sensing (IPAS), School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia.

School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia.

出版信息

Front Mol Biosci. 2021 Jan 12;7:621366. doi: 10.3389/fmolb.2020.621366. eCollection 2020.

DOI:10.3389/fmolb.2020.621366
PMID:33511160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835888/
Abstract

The impact of invasive fungal infections on human health is a serious, but largely overlooked, public health issue. Commonly affecting the immunocompromised community, fungal infections are predominantly caused by species of , and . Treatments are reliant on the aggressive use of pre-existing antifungal drug classes that target the fungal cell wall and membrane. Despite their frequent use, these drugs are subject to unfavorable drug-drug interactions, can cause undesirable side-effects and have compromised efficacy due to the emergence of antifungal resistance. Hence, there is a clear need to develop novel classes of antifungal drugs. A promising approach involves exploiting the metabolic needs of fungi by targeted interruption of essential metabolic pathways. This review highlights potential antifungal targets including enolase, a component of the enolase-plasminogen complex, and enzymes from the mannitol biosynthesis and purine nucleotide biosynthesis pathways. There has been increased interest in the enzymes that comprise these particular pathways and further investigation into their merits as antifungal targets and roles in fungal survival and virulence are warranted. Disruption of these vital processes by targeting unconventional pathways with small molecules or antibodies may serve as a promising approach to discovering novel classes of antifungals.

摘要

侵袭性真菌感染对人类健康的影响是一个严重但在很大程度上被忽视的公共卫生问题。真菌感染通常影响免疫功能低下人群,主要由 、 和 的某些物种引起。治疗依赖于积极使用针对真菌细胞壁和细胞膜的现有抗真菌药物类别。尽管这些药物经常使用,但它们存在不良的药物相互作用,会引起不良副作用,并且由于抗真菌耐药性的出现而疗效受损。因此,显然需要开发新型抗真菌药物。一种有前景的方法是通过有针对性地中断基本代谢途径来利用真菌的代谢需求。本综述重点介绍了潜在的抗真菌靶点,包括烯醇化酶(烯醇化酶 - 纤溶酶原复合物的一个组成部分)以及来自甘露醇生物合成和嘌呤核苷酸生物合成途径的酶。人们对构成这些特定途径的酶的兴趣日益增加,有必要进一步研究它们作为抗真菌靶点的优点以及在真菌存活和毒力中的作用。通过用小分子或抗体靶向非常规途径来破坏这些重要过程,可能是发现新型抗真菌药物的一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/e7b01e44a5ed/fmolb-07-621366-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/62b0b5dfa840/fmolb-07-621366-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/9aabe057741a/fmolb-07-621366-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/9c27ceaed94c/fmolb-07-621366-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/b6272e587faa/fmolb-07-621366-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/e7b01e44a5ed/fmolb-07-621366-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/62b0b5dfa840/fmolb-07-621366-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/9aabe057741a/fmolb-07-621366-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/9c27ceaed94c/fmolb-07-621366-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/b6272e587faa/fmolb-07-621366-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/7835888/e7b01e44a5ed/fmolb-07-621366-g0005.jpg

相似文献

1
Targeting Unconventional Pathways in Pursuit of Novel Antifungals.靶向非常规途径以寻求新型抗真菌药物
Front Mol Biosci. 2021 Jan 12;7:621366. doi: 10.3389/fmolb.2020.621366. eCollection 2020.
2
Antifungal Drugs: The Current Armamentarium and Development of New Agents.抗真菌药物:现有武器库和新药物的研发。
Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.FUNK-0002-2016.
3
Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.海藻糖生物合成途径在人类真菌感染发病机制中的核心作用:治疗开发的机遇与挑战
Microbiol Mol Biol Rev. 2017 Mar 15;81(2). doi: 10.1128/MMBR.00053-16. Print 2017 Jun.
4
Elucidating drug resistance in human fungal pathogens.阐明人类真菌病原体的耐药性。
Future Microbiol. 2014;9(4):523-42. doi: 10.2217/fmb.14.18.
5
Structural and Studies on Trehalose-6-Phosphate Synthase from Pathogenic Fungi Provide Insights into Its Catalytic Mechanism, Biological Necessity, and Potential for Novel Antifungal Drug Design.致病真菌中海藻糖-6-磷酸合酶的结构与研究为其催化机制、生物学必要性及新型抗真菌药物设计潜力提供了见解。
mBio. 2017 Jul 25;8(4):e00643-17. doi: 10.1128/mBio.00643-17.
6
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.人类致病酵母和丝状真菌的耐药性:流行情况、潜在分子机制以及与人类和环境中抗真菌药物使用的关联
Dan Med J. 2016 Oct;63(10).
7
Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance.烟曲霉麦角固醇生物合成:作为抗真菌靶点的相关性及其在抗真菌药物耐药性中的作用。
Front Microbiol. 2013 Jan 10;3:439. doi: 10.3389/fmicb.2012.00439. eCollection 2012.
8
New treatment options for critically important WHO fungal priority pathogens.针对世界卫生组织极为重要的真菌重点病原体的新治疗选择。
Clin Microbiol Infect. 2025 Jun;31(6):922-930. doi: 10.1016/j.cmi.2024.03.006. Epub 2024 Mar 9.
9
Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.酰腙类化合物作为抗真菌药物作用靶点:靶向真菌鞘脂类的合成。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.00156-18. Print 2018 May.
10
Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.常用肿瘤药物降低抗真菌药物对念珠菌属和曲霉菌属的疗效。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00504-18. Print 2018 Jul.

引用本文的文献

1
An integrated systems biology approach establishes arginine biosynthesis as a metabolic weakness in Candida albicans during host infection.一种综合的系统生物学方法确定精氨酸生物合成是白色念珠菌在宿主感染期间的代谢弱点。
Cell Commun Signal. 2025 Aug 4;23(1):362. doi: 10.1186/s12964-025-02306-9.
2
Polypeptides Targeting Drk1.靶向Drk1的多肽
J Fungi (Basel). 2023 Sep 29;9(10):980. doi: 10.3390/jof9100980.
3
Conidial Germination Is Dominated by Pathogenicity Factors and Effectors.分生孢子萌发受致病性因子和效应子的主导。

本文引用的文献

1
Nucleoside selectivity of Aspergillus fumigatus nucleoside-diphosphate kinase.烟曲霉核苷二磷酸激酶的核苷选择性。
FEBS J. 2021 Apr;288(7):2398-2417. doi: 10.1111/febs.15607. Epub 2020 Nov 6.
2
Genome-wide functional analysis of phosphatases in the pathogenic fungus Cryptococcus neoformans.新型隐球菌致病真菌中磷酸酶的全基因组功能分析。
Nat Commun. 2020 Aug 24;11(1):4212. doi: 10.1038/s41467-020-18028-0.
3
Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018.
J Fungi (Basel). 2023 Sep 27;9(10):970. doi: 10.3390/jof9100970.
4
Selective Metal Chelation by a Thiosemicarbazone Derivative Interferes with Mitochondrial Respiration and Ribosome Biogenesis in Candida albicans.硫代半卡巴腙衍生物的选择性金属螯合作用干扰白念珠菌的线粒体呼吸和核糖体生物发生。
Microbiol Spectr. 2022 Jun 29;10(3):e0195121. doi: 10.1128/spectrum.01951-21. Epub 2022 Apr 18.
5
Emerging Antifungal Targets and Strategies.新兴抗真菌靶点和策略。
Int J Mol Sci. 2022 Mar 2;23(5):2756. doi: 10.3390/ijms23052756.
6
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis.侵袭性念珠菌病的耐药性及新的治疗方法。
Front Cell Infect Microbiol. 2021 Dec 14;11:759408. doi: 10.3389/fcimb.2021.759408. eCollection 2021.
7
Prospects for anti- therapy through targeting the cell wall: A mini-review.通过靶向细胞壁进行抗治疗的前景:一篇综述。
Cell Surf. 2021 Oct 16;7:100063. doi: 10.1016/j.tcsw.2021.100063. eCollection 2021 Dec.
在荷兰全国多中心监测项目中,2013-2018 年烟曲霉对唑类药物耐药的矛盾趋势。
Emerg Infect Dis. 2020 Jul;26(7):1447-1455. doi: 10.3201/eid2607.200088.
4
Antifungal Drugs.抗真菌药物
Metabolites. 2020 Mar 12;10(3):106. doi: 10.3390/metabo10030106.
5
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?侵袭性真菌病分子诊断的新时代:我们准备好了吗?
Front Microbiol. 2020 Jan 14;10:2903. doi: 10.3389/fmicb.2019.02903. eCollection 2019.
6
Enolase From Is a Moonlighting Protein That Binds the Human Plasma Complement Proteins Factor H, FHL-1, C4BP, and Plasminogen.烯醇酶是一种具有双重功能的蛋白质,可结合人血浆补体蛋白因子 H、FHL-1、C4BP 和纤溶酶原。
Front Immunol. 2019 Nov 22;10:2573. doi: 10.3389/fimmu.2019.02573. eCollection 2019.
7
Antifungal Agents in Agriculture: Friends and Foes of Public Health.农业用抗真菌剂:公共卫生的益友与劲敌。
Biomolecules. 2019 Sep 23;9(10):521. doi: 10.3390/biom9100521.
8
Molecular and structural basis of nucleoside diphosphate kinase-mediated regulation of spore and sclerotia development in the fungus .核苷二磷酸激酶介导调控真菌孢子和菌核发育的分子和结构基础。
J Biol Chem. 2019 Aug 16;294(33):12415-12431. doi: 10.1074/jbc.RA119.007505. Epub 2019 Jun 26.
9
Structure, Mechanism, and Inhibition of Thioredoxin Reductase.硫氧还蛋白还原酶的结构、机制和抑制。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02281-18. Print 2019 Mar.
10
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.抗真菌苯并[b]噻吩 1,1-二氧化物 IMPDH 抑制剂表现出泛分析干扰 (PAINS)特征。
Bioorg Med Chem. 2018 Nov 1;26(20):5408-5419. doi: 10.1016/j.bmc.2018.09.004. Epub 2018 Sep 5.